A detailed history of Signature Estate & Investment Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Signature Estate & Investment Advisors LLC holds 6,296 shares of NVO stock, worth $554,551. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,296
Previous 6,185 1.79%
Holding current value
$554,551
Previous $736,000 26.49%
% of portfolio
0.01%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$85.0 - $120.04 $9,435 - $13,324
111 Added 1.79%
6,296 $541,000
Q3 2024

Nov 06, 2024

BUY
$119.07 - $145.42 $5,715 - $6,980
48 Added 0.78%
6,185 $736,000
Q2 2024

Jul 25, 2024

BUY
$122.71 - $146.91 $753,071 - $901,586
6,137 New
6,137 $875,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $199B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Signature Estate & Investment Advisors LLC Portfolio

Follow Signature Estate & Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Estate & Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signature Estate & Investment Advisors LLC with notifications on news.